ZBTB11 dysfunction: spectrum of brain abnormalities, biochemical signature and cellular consequences.

RNA-sequencing ZBTB11 chromatin immunoprecipitation (ChIP)-sequencing malonic aciduria methylmalonic aciduria

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
29 07 2022
Historique:
received: 31 03 2021
revised: 07 12 2021
accepted: 20 12 2021
pubmed: 2 2 2022
medline: 3 8 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Bi-allelic pathogenic variants in ZBTB11 have been associated with intellectual developmental disorder, autosomal recessive 69 (MRT69; OMIM 618383). We report five patients from three families with novel, bi-allelic variants in ZBTB11. We have expanded the clinical phenotype of MRT69, documenting varied severity of atrophy affecting different brain regions and described combined malonic and methylmalonic aciduria as a biochemical manifestation. As ZBTB11 encodes for a transcriptional regulator, we performeded chromatin immunoprecipitation-sequencing targeting ZBTB11 in fibroblasts from patients and controls. Chromatin immunoprecipitation-sequencing revealed binding of wild-type ZBTB11 to promoters in 238 genes, among which genes encoding proteins involved in mitochondrial functions and RNA processing are over-represented. Mutated ZBTB11 showed reduced binding to 61 of the targeted genes, indicating that the variants act as loss of function. Most of these genes are related to mitochondrial functions. Transcriptome analysis of the patient fibroblasts revealed dysregulation of mitochondrial functions. In addition, we uncovered that reduced binding of the mutated ZBTB11 to ACSF3 leads to decreased ACSF3 transcript level, explaining combined malonic and methylmalonic aciduria. Collectively, these results expand the clinical spectrum of ZBTB11-related neurological disease and give insight into the pathophysiology in which the dysfunctional ZBTB11 affect mitochondrial functions and RNA processing contributing to the neurological and biochemical phenotypes.

Identifiants

pubmed: 35104841
pii: 6519384
doi: 10.1093/brain/awac034
pmc: PMC9337812
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2602-2616

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Hum Mol Genet. 2019 May 1;28(9):1548-1560
pubmed: 30624672
Mitochondrion. 2004 Sep;4(5-6):395-401
pubmed: 16120401
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Sci Rep. 2021 Jun 7;11(1):11997
pubmed: 34099816
Hum Mutat. 2019 Nov;40(11):1968-1984
pubmed: 31343797
J Biol Chem. 2011 Sep 30;286(39):33729-36
pubmed: 21846720
Clin Chem. 2007 Apr;53(4):729-34
pubmed: 17332151
Immunol Cell Biol. 2014 Jul;92(6):481-8
pubmed: 24638067
Nucleic Acids Res. 1993 Jul 25;21(15):3341-6
pubmed: 8346014
Hum Mutat. 2020 Dec;41(12):2179-2194
pubmed: 33131181
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Int J Mol Sci. 2020 Nov 06;21(21):
pubmed: 33171986
Tidsskr Nor Laegeforen. 2009 Feb 12;129(4):281-6
pubmed: 19219092
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cell Death Differ. 2015 Apr;22(4):626-42
pubmed: 25342469
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Genome Biol. 2005;6(10):R82
pubmed: 16207353
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell. 2017 Jun 1;66(5):711-720.e3
pubmed: 28529057
Bioinformatics. 2012 Feb 15;28(4):599-600
pubmed: 22210868
Nat Biotechnol. 2008 Dec;26(12):1351-9
pubmed: 19029915
Hum Mol Genet. 2018 Sep 15;27(18):3177-3188
pubmed: 29893856
Eur J Paediatr Neurol. 2018 Jan;22(1):46-55
pubmed: 29122497
Clin Genet. 1995 Jul;48(1):1-5
pubmed: 7586637
Nucleic Acids Res. 2014 Jan;42(Database issue):D749-55
pubmed: 24316576
Eur J Neurosci. 2006 Oct;24(8):2177-90
pubmed: 17074043
J Pediatr. 2010 Jun;156(6):907-913.e2
pubmed: 20304425
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Bioinformatics. 2006 Jan 15;22(2):195-201
pubmed: 16301204
Nat Commun. 2020 Oct 29;11(1):5469
pubmed: 33122634
Nat Genet. 2011 Aug 14;43(9):883-6
pubmed: 21841779
Eur J Neurol. 2004 Mar;11(3):163-86
pubmed: 15009163
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nat Commun. 2017 Apr 06;8:14911
pubmed: 28382966
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Neuron. 2017 Aug 2;95(3):473-475
pubmed: 28772115
Am J Hum Genet. 2019 Jun 6;104(6):1182-1201
pubmed: 31130284
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
J Inherit Metab Dis. 2019 Jan;42(1):107-116
pubmed: 30740739
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Bioenerg Biomembr. 2001 Jun;33(3):259-66
pubmed: 11695836
J Biol Chem. 1951 Apr;189(2):665-70
pubmed: 14832284
Cereb Cortex. 2020 May 18;30(6):3781-3799
pubmed: 32043120
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713

Auteurs

Dulika Sumathipala (D)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Petter Strømme (P)

Division of Pediatric and Adolescent Medicine, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.

Zohreh Fattahi (Z)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Torben Lüders (T)

Department of Clinical Molecular Biology, Section of Clinical Molecular Biology (EpiGen), University of Oslo and Akershus University Hospital, Lørenskog, Norway.

Ying Sheng (Y)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Kimia Kahrizi (K)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Ingunn Holm Einarsen (IH)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Jennifer L Sloan (JL)

Organic Acid Research Section, Medical Genomics and Metabolic Genetics Branch, NHGRI, NIH, Bethesda, MD, USA.

Hossein Najmabadi (H)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Lambert van den Heuvel (L)

Translational Metabolic Laboratory, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Ron A Wevers (RA)

Translational Metabolic Laboratory, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
United for Metabolic Disease-UMD, The Netherlands.

Sergio Guerrero-Castillo (S)

University Children's Research@Kinder-UKE, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Lars Mørkrid (L)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Vassili Valayannopoulos (V)

Necker-Enfants Malades University Hospital and IMAGINE Institute, Paris, France.

Paul Hoff Backe (PH)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Department of Microbiology, Oslo University Hospital, Oslo, Norway.

Charles P Venditti (CP)

Organic Acid Research Section, Medical Genomics and Metabolic Genetics Branch, NHGRI, NIH, Bethesda, MD, USA.

Clara D van Karnebeek (CD)

Translational Metabolic Laboratory, Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
United for Metabolic Disease-UMD, The Netherlands.
Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.

Hilde Nilsen (H)

Department of Clinical Molecular Biology, Section of Clinical Molecular Biology (EpiGen), University of Oslo and Akershus University Hospital, Lørenskog, Norway.

Eirik Frengen (E)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Doriana Misceo (D)

Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH